These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 19327866

  • 21. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.
    Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam JB, Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD.
    J Clin Oncol; 2005 Feb 20; 23(6):1136-43. PubMed ID: 15718309
    [Abstract] [Full Text] [Related]

  • 22. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA.
    Cancer; 2005 May 15; 103(10):2006-14. PubMed ID: 15812825
    [Abstract] [Full Text] [Related]

  • 23. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A, Shirakusa T, Miyoshi T, Hamada T, Enatsu S, Maekawa S, Hiratsuka M.
    Thorac Cardiovasc Surg; 2006 Feb 15; 54(1):42-6. PubMed ID: 16485188
    [Abstract] [Full Text] [Related]

  • 24. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL, Mönig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, Schneider PM, Hölscher AH.
    J Surg Oncol; 2003 Apr 15; 82(4):256-60. PubMed ID: 12672010
    [Abstract] [Full Text] [Related]

  • 25. Tumor volume and tumor marker index based on CYFRA 21-1 and CEA are strong prognostic factors in operated early stage NSCLC.
    Muley T, Fetz TH, Dienemann H, Hoffmann H, Herth FJ, Meister M, Ebert W.
    Lung Cancer; 2008 Jun 15; 60(3):408-15. PubMed ID: 18083270
    [Abstract] [Full Text] [Related]

  • 26. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
    Rena O, Carsana L, Cristina S, Papalia E, Massera F, Errico L, Bozzola C, Casadio C.
    Eur J Cardiothorac Surg; 2007 Dec 15; 32(6):863-7. PubMed ID: 17936004
    [Abstract] [Full Text] [Related]

  • 27. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H, De Leyn P, Vansteenkiste J, Dooms C, Van Raemdonck D, Nafteux P, Coosemans W, Lerut T.
    Eur J Cardiothorac Surg; 2009 Sep 15; 36(3):433-9. PubMed ID: 19502079
    [Abstract] [Full Text] [Related]

  • 28. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W, Dango S, Kirschbaum A, Cucuruz B, Hörth W, Stremmel C, Passlick B.
    Eur J Cardiothorac Surg; 2008 Apr 15; 33(4):728-34. PubMed ID: 18261918
    [Abstract] [Full Text] [Related]

  • 29. [Establishment and evaluation of a prognostic prediction model for patients after complete resection of non-small cell lung cancer and multidisciplinary therapy].
    Wei WD, Fu JH, Lin P, Li XD, Yang H, Rong TH, Chen LK.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep 15; 30(9):672-5. PubMed ID: 19173908
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y.
    Ann Thorac Surg; 2006 Jan 15; 81(1):292-7. PubMed ID: 16368383
    [Abstract] [Full Text] [Related]

  • 36. A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer.
    Goodgame B, Viswanathan A, Miller CR, Gao F, Meyers B, Battafarano RJ, Patterson A, Cooper J, Guthrie TJ, Bradley J, Pillot G, Govindan R.
    Am J Clin Oncol; 2008 Feb 15; 31(1):22-8. PubMed ID: 18376223
    [Abstract] [Full Text] [Related]

  • 37. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?
    Port JL, Korst RJ, Lee PC, Kansler AL, Kerem Y, Altorki NK.
    Ann Thorac Surg; 2007 Feb 15; 83(2):397-400. PubMed ID: 17257959
    [Abstract] [Full Text] [Related]

  • 38. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F, Marulli G, Callegaro D, Zuin A, Gobbi T, Loy M, Sartori F.
    Lung Cancer; 2004 Aug 15; 45(2):215-20. PubMed ID: 15246193
    [Abstract] [Full Text] [Related]

  • 39. Metastatic lymph node size and colorectal cancer prognosis.
    Dhar DK, Yoshimura H, Kinukawa N, Maruyama R, Tachibana M, Kohno H, Kubota H, Nagasue N.
    J Am Coll Surg; 2005 Jan 15; 200(1):20-8. PubMed ID: 15631916
    [Abstract] [Full Text] [Related]

  • 40. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
    Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Chansky K, Kelly K, Adjei AA, Jett JR.
    Cancer; 2006 Aug 15; 107(4):781-92. PubMed ID: 16847887
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.